Latest filing published 03 Jul 2025 for PMV Pharmaceuticals, Inc., €25k.
Michael Carulli is a declared insider of PMV Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 18 January 2024 to 1 July 2025.
Sales make up the whole of the open-market record (2 sales, €29k). Other entries cover 1 share grant. So far in 2025, the count stands at no purchases and 1 sale.
The record was last updated on 3 July 2025 with an open-market sale (€25k) in PMV Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations